CD276 and cancer: Immunohistochemistry staining with CD31, a specific endothelial marker for validating MVD demonstrated a positive correlation with the expression of B7-H3 in CRC tissue, which increased with lymph node metastasis and advanced stage of cancer (stage III and IV) [27].